# Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

> **NCT01435915** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT01435915
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-28
- **Primary completion:** 2010-08-05
- **Final completion:** 2010-08-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435915, "Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01435915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*